(Total Views: 1073)
Posted On: 06/08/2023 3:47:34 PM
Post# of 154847
Re: biloxiblues #134874
If that gets you excited wait until you see this -
https://www.globaldata.com/store/?s=cytodyn
GlobalData is in the business of slapping together reports with a techy veneer of "machine learning algorithm". The first sentence should clue you in to how sloppy they are. "Leronlimab is under clinical development by Cytodyn and currently in Phase II for Lung Cancer."
Unless you've never heard of leronlimab you will learn nothing new and the prospects of approval angle is not valid. But they must have the suckers lined up since they keep pumping out those reports.
But I can tell you that CCR5 is highly elevated in lung cancers and aids in it's progression so there is a very high likelihood that leronlimab will be effective.
https://www.globaldata.com/store/?s=cytodyn
GlobalData is in the business of slapping together reports with a techy veneer of "machine learning algorithm". The first sentence should clue you in to how sloppy they are. "Leronlimab is under clinical development by Cytodyn and currently in Phase II for Lung Cancer."
Unless you've never heard of leronlimab you will learn nothing new and the prospects of approval angle is not valid. But they must have the suckers lined up since they keep pumping out those reports.
But I can tell you that CCR5 is highly elevated in lung cancers and aids in it's progression so there is a very high likelihood that leronlimab will be effective.
(16)
(0)
